Carmena, R <br/><br/>
The response to lovastatin treatment in patients with heterozygous familial hypercholesterolemia is modulated by apolipoprotein E polymorphism.  [electronic resource] 

 -  Metabolism: clinical and experimental  Jul 1993 
 - 895-901 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0026-0495 
<br/><br/><label>Standard No.: </label>10.1016/0026-0495(93)90066-w  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Apolipoproteins E--genetics<br/>Female<br/>Heterozygote<br/>Humans<br/>Hyperlipoproteinemia Type II--blood<br/>Lipids--blood<br/>Lovastatin--therapeutic use<br/>Male<br/>Middle Aged<br/>Phenotype<br/>Polymorphism, Genetic<br/>Receptors, LDL--genetics<br/>Retrospective Studies